Clinical TrialTerminated

Intensive 7-day Treatment for PTSD Combining Ketamine With Exposure Therapy

Phase II pilot trial (Yale University; PI: Ilan Harpaz-Rotem PhD; NCT02727998). Status: TERMINATED. Participants: n=28 enrolled; adults with PTSD. Intervention: intensive 7-day treatment combining a single IV ketamine infusion with prolonged exposure therapy. Start: December 2015; end: November 2021. CT.gov: 0 refs listed. Linked paper: Duek O, Korem N, Li Y, Kelmendi B (Yale/VA Connecticut) — Neuropsychopharmacology 2023 (PMID 37270621): neural imaging analysis showing long-term structural and functional changes following a single ketamine infusion in participants with PTSD.

Target Enrollment
28 participants
Study Type
interventional
Design
Non-randomized

Study Details

  • Status
    Terminated
  • Type
    interventional
  • Design
    Non-randomized
  • Target Enrollment28 participants
  • Timeline
    Start: 2015-12-01
    End: 2021-11-28

Related Publications

Long term structural and functional neural changes following a single infusion of Ketamine in PTSD

Published
Authors
Duek, O., Korem, N., Li, Y., Kelmendi, B., Amen, S., Gordon, C., Milne, M., Krystal, J. H., Levy, I., Harpaz-Rotem, I.

Your Library

Intensive 7-day Treatment for PTSD Combining... — Clinical Trial Details | Blossom